ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 780

$1.12M Total Retail Price of All Prescriptions

Rank: 49 out of 780

725 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 725 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 725 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 20,031 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,191 784 S3 1 1
SIMVASTATIN 1,167 903 2 2
LISINOPRIL 1,097 850 3 6
AMLODIPINE BESYLATE 915 702 4 4
OMEPRAZOLE 688 496 5 3
LEVOTHYROXINE SODIUM 622 535 6 5
PRAVASTATIN SODIUM 618 437 7 9
FUROSEMIDE 586 463 8 7
HYDROCHLOROTHIAZIDE 501 352 9 10
MELOXICAM 498 339 10 16
GLIMEPIRIDE 484 342 11 30
METOPROLOL SUCCINATE 458 362 12 20
POTASSIUM CHLORIDE 428 349 13 11
MIRTAZAPINE 423 361 14 58
CARVEDILOL 414 316 15 14
ZOLPIDEM TARTRATE 376 277 16 17
METFORMIN HCL ER 372 269 17 43
METOPROLOL TARTRATE 359 283 18 19
GABAPENTIN 350 235 19 13
METFORMIN HCL 347 245 20 8
ATORVASTATIN CALCIUM 341 295 21 12
CITALOPRAM HBR 340 261 22 23
TRAMADOL HCL 332 228 23 15
NAMENDA 328 328 24 46
PANTOPRAZOLE SODIUM 325 231 25 25
DONEPEZIL HCL 316 316 26 31
ATENOLOL 280 254 27 21
TRIAMTERENE-HCTZ 260 185 28 37
SERTRALINE HCL 255 179 29 27
TAMSULOSIN HCL 245 213 30 36
CRESTOR 218 183 31 32
WARFARIN SODIUM 216 169 32 24
CLONIDINE HCL 213 132 33 28
EXELON 211 200 34 132
NEXIUM 208 123 35 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 203 142 36 26
AMLODIPINE BESYLATE-BENAZEPRIL 193 137 37 50
CLOPIDOGREL 190 151 38 34
LOVASTATIN 181 177 39 47
LOSARTAN POTASSIUM 169 133 40 18
ALENDRONATE SODIUM 166 165 41 44
RISPERIDONE 165 165 42 98
LANTUS 155 130 43 71
PREDNISONE 143 86 44 40
TRAZODONE HCL 142 88 45 35
CYMBALTA 138 90 46 51
CYCLOBENZAPRINE HCL 135 79 R 47 42
SPIRONOLACTONE 131 87 48 53
PLAVIX 130 104 49 45
NOVOLIN R 129 109 50 212
AZITHROMYCIN 120 77 51 38
HUMULIN 70-30 119 107 52 106
VERAPAMIL ER 116 89 53 78
BENAZEPRIL HCL 114 90 54 59
FOSINOPRIL SODIUM 113 100 55 112
ADVAIR DISKUS 105 88 56 68
PAROXETINE HCL 105 66 56 69
PHENYTOIN SODIUM EXTENDED 104 51 58 128
DIVALPROEX SODIUM 98 98 59 119
KLOR-CON M20 94 69 60 57
KLOR-CON 10 94 56 60 90
FLUTICASONE PROPIONATE 93 67 62 41
QUETIAPINE FUMARATE 89 76 63 81
TRIAMTERENE-HYDROCHLOROTHIAZID 87 56 64 162
NAPROXEN 85 44 65 100
LEVETIRACETAM 82 49 66 130
ALLOPURINOL 80 66 67 29
RAMIPRIL 80 71 67 70
HYDRALAZINE HCL 80 60 67 54
INSULIN SYRINGE 78 57 70 80
LOSARTAN-HYDROCHLOROTHIAZIDE 77 59 71 33
LYRICA 76 63 72 52
FELODIPINE ER 76 64 72 126
DOXAZOSIN MESYLATE 75 61 74 97
DIOVAN HCT 74 64 75 75
NIFEDIPINE ER 72 55 76 115
VENTOLIN HFA 71 50 77 91
PROAIR HFA 70 45 78 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 62 78 88
MECLIZINE HCL 70 69 78 83
PROMETHAZINE HCL 70 27 R 78 66
DIGOXIN 70 54 78 56
CARISOPRODOL 67 0 R 83 67
CIPROFLOXACIN HCL 66 60 84 49
GLYBURIDE 65 49 R 85 101
ENALAPRIL MALEATE 64 60 86 64
DIOVAN 63 63 87 55
FLUOXETINE HCL 62 38 88 65
SYNTHROID 62 50 88 77
ESCITALOPRAM OXALATE 62 44 88 61
NOVOLOG 60 37 91 158
BENZTROPINE MESYLATE 59 59 R 92 223
CARBIDOPA-LEVODOPA 59 59 92 124
RANITIDINE HCL 58 58 94 39
METHOCARBAMOL 56 26 R 95 84
OXYBUTYNIN CHLORIDE ER 55 49 96 169
GLUCAGEN 55 38 96 430
SPIRIVA 53 21 98 72
CELEBREX 53 33 98 89
BUMETANIDE 51 44 100 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.